Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 55 Records) |
| Query Trace: Carcinoma and SETD2[original query] |
|---|
| SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
| Molecular subtype classification of papillary renal cell cancer using miRNA expression. OncoTargets and therapy 2019 12 2311-2322. Yu Changwen, Dai Danjing, Xie Ju |
| Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors. PloS one 2019 4 14 (4): e0209134. Morcillo-Garcia Sara, Noblejas-Lopez Maria Del Mar, Nieto-Jimenez Cristina, Perez-Peña Javier, Nuncia-Cantarero Miriam, Gy?rffy Balázs, Amir Eitan, Pandiella Atanasio, Galan-Moya Eva M, Ocana Alber |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. BMC urology 2020 Aug 20 (1): 125. Suh Jungyo, Jeong Chang Wook, Choi Seongmin, Ku Ja Hyeon, Kim Hyeon Hoe, Kim Kwangsoo, Kwak Che |
| Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis. Journal for immunotherapy of cancer 2020 7 8 (2): . Dizman Nazli, Lyou Yung, Salgia Nicholas, Bergerot Paulo Gustavo, Hsu JoAnn, Enriquez Daniel, Izatt Tyler, Trent Jeffrey M, Byron Sara, Pal Suman |
| Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. Nature communications 2020 2 11 (1): 739. Wang Xiang-Ming, Lu Yang, Song Yi-Meng, Dong Jun, Li Ruo-Yan, Wang Guo-Liang, Wang Xu, Zhang Shu-Dong, Dong Zhou-Huan, Lu Min, Wang Shi-Yu, Ge Li-Yuan, Luo Guang-Da, Ma Run-Zhuo, George Rozen Steve, Bai Fan, Wu Di, Ma Lu-L |
| Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data. Annals of translational medicine 2020 12 8 (21): 1389. Kim Ji-Yeon, Jeong Hyoung-Oh, Heo Dae Seog, Keam Bhumsuk, Moon Kyung Chul, Kwak Cheol, Jang Jinho, Kim Seunghoon, Kim Jong-Il, Lee Semin, Lee Se-Ho |
| 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. BMC urology 2020 10 20 (1): 173. Eckel-Passow Jeanette E, Yan Huihuang, Kosel Matthew L, Serie Daniel, Decker Paul A, Jenkins Robert B, Costello Brian, Leibovich Bradley, Ho Thai H, Parker Alexand |
| Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic oncology 2021 9 39 (11): 791.e17-791.e24. Mano Roy, Duzgol Cihan, Ganat Maz, Goldman Debra A, Blum Kyle A, Silagy Andrew W, Walasek Aleksandra, Sanchez Alejandro, DiNatale Renzo G, Marcon Julian, Kashan Mahyar, Becerra Maria F, Benfante Nicole E, Coleman Jonathan A, Kattan Michael W, Russo Paul, Akin Oguz, Ostrovnaya Irina, Hakimi A A |
| Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. Cancers 2021 5 13 (9): . Moore Ariane L, Batavia Aashil A, Kuipers Jack, Singer Jochen, Burcklen Elodie, Schraml Peter, Beisel Christian, Moch Holger, Beerenwinkel Ni |
| Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma. Aging 2021 4 13 (7): 9960-9975. Zeng Hao, Chen Linyan, Wang Manni, Luo Yuling, Huang Yeqian, Ma Xuel |
| Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. International journal of cancer 2021 Feb . Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus |
| Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science 2021 10 113 (1): 297-307. Yoshikawa Yoshie, Yamada Yusuke, Emi Mitsuru, Atanesyan Lilit, Smout Jan, de Groot Karel, Savola Suvi, Nakanishi-Shinkai Yukako, Kanematsu Akihiro, Nojima Michio, Ohmuraya Masaki, Hashimoto-Tamaoki Tomoko, Yamamoto Shin |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma. Translational andrology and urology 2020 Dec 9 (6): 2751-2763. Bi Hai, Yin Jipeng, Zhou Lang, Wu Yaqian, Ge Liyuan, Lu Min, Liu Lei, Zhang Hongxian, Zhao Yongzhe, Liu Cheng, Ma Lul |
| The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Molecular oncology 2022 3 16 (12): 2384-2395. van der Mijn Johannes C, Eng Kenneth W, Chandra Pooja, Fernandez Evan, Ramazanoglu Sinan, Sigaras Alexandros, Oromendia Clara, Gudas Lorraine J, Tagawa Scott T, Nanus David M, Faltas Bishoy F, Beltran Himisha, Sternberg Cora N, Elemento Olivier, Sboner Andrea, Mosquera Juan Miguel, Molina Ana |
| A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. BMC medical genomics 2022 1 15 (1): 1. Zhang Huaru, Lu Xiaojun, Huang Gang, Hua Meimian, Zhang Wenhui, Wang Tao, Huang Liqun, Wang Ziwei, Chen Qing, Li Jing, Yang Qing, Yang Guoshe |
| Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel. Journal of personalized medicine 2022 Jan 12 (1): . Hwang Jia, Kim Heeeun, Han Jinseon, Lee Jieun, Hong Sunghoo, Kim Saewoong, Yoon Sungjoo Kim, Choi Keonwoo, Yang Jihoon, Park Unsang, Kim Kwangjoong, Yim Kwangil, Kim Yuil, Choi Yeongj |
| T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 2022 1 11 (1): 1993042. Lee Moon Hee, Järvinen Petrus, Nísen Harry, Brück Oscar, Ilander Mette, Uski Ilona, Theodoropoulos Jason, Kankainen Matti, Mirtti Tuomas, Mustjoki Satu, Kreutzman An |
| Genomic characterization of thymic epithelial tumors in a real-world dataset. ESMO open 2023 9 8 (5): 101627. K Kurokawa, T Shukuya, R A Greenstein, B G Kaplan, H Wakelee, J S Ross, K Miura, K Furuta, S Kato, J Suh, S Sivakumar, E S Sokol, D P Carbone, K Takahas |
| SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, Xuesong Zhang, Truong Lam, Anh Hoang, Elshad Hasanov, Ganiraju Manyam, Christine B Peterson, Haifeng Zhu, Shwetha V Kumar, Rehan Akbani, Patrick G Pilie, Nizar M Tannir, Guang Peng, Eric Jonas |
| Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
| Genomic profiles of renal cell carcinoma in a small Chinese cohort. Frontiers in oncology 2023 7 13 1095775. Sheng Tai, Dan-Dan Xu, Zhixian Yu, Yu Guan, Shuiping Yin, Jun Xiao, Song Xue, Chaozhao Lia |
| Differences in mutations across tumour sizes in clear-cell renal cell carcinoma. BJU international 2024 9 . Steven M Monda, Benjamin W Carney, Allison M May, Shuchi Gulati, Simpa S Salami, Thenappan Chandrasekar, Evan T Keller, Nicolai A Huebner, Ganesh S Palapattu, Marc A Dall'E |
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 2024 6 12 918. Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortz |
| Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma with Synchronous and Metachronous Nodal Disease. Urology practice 2024 6 101097UPJ0000000000000623. Lennert Eismann, Mark Zucker, Mark T Dawidek, Stephen W Reese, Lina Posada Calderon, Andreas Aulitzky, Christian G Stief, Jonathan A Coleman, Ritesh R Kotecha, Maria Carlo, Yingbei Chen, Eduard Reznik, Paul Russo, A Ari Haki |
| Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers 2024 5 16 (10): . Corbin J Eule, Junxiao Hu, Dale Hedges, Alkesh Jani, Thomas Pshak, Brandon J Manley, Alejandro Sanchez, Robert Dreicer, Zin W Myint, Yousef Zakharia, Elaine T L |
| Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
- Page last reviewed:Feb 1, 2024
- Content source: